KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Depreciation & Amortization (CF) (2016 - 2026)

Sarepta Therapeutics has reported Depreciation & Amortization (CF) over the past 15 years, most recently at $5.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 49.76% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $44.5 million, up 18.02%, while the annual FY2025 figure was $44.5 million, 18.02% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $5.3 million at Sarepta Therapeutics, down from $18.4 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $18.4 million in Q3 2025 and troughed at $5.3 million in Q4 2025.
  • A 5-year average of $10.3 million and a median of $10.5 million in 2021 define the central range for Depreciation & Amortization (CF).
  • On a YoY basis, Depreciation & Amortization (CF) climbed as much as 88.15% in 2025 and fell as far as 49.76% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $10.1 million in 2021, then grew by 4.02% to $10.6 million in 2022, then rose by 7.76% to $11.4 million in 2023, then decreased by 8.06% to $10.5 million in 2024, then tumbled by 49.76% to $5.3 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SRPT at $5.3 million in Q4 2025, $18.4 million in Q3 2025, and $10.8 million in Q2 2025.